- Home
- CVKD vs ADN Comparison
CVKD vs ADN Comparison
Compare CVKD & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- ADN
- Stock Information
- Founded
- CVKD 2022
- ADN 2006
- Country
- CVKD United States
- ADN United States
- Employees
- CVKD N/A
- ADN N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- ADN Power Generation
- Sector
- CVKD Health Care
- ADN Utilities
- Exchange
- CVKD Nasdaq
- ADN Nasdaq
- Market Cap
- CVKD 29.5M
- ADN 6.6M
- IPO Year
- CVKD 2023
- ADN N/A
- Fundamental
- Price
- CVKD $12.95
- ADN $1.95
- Analyst Decision
- CVKD Strong Buy
- ADN
- Analyst Count
- CVKD 1
- ADN 0
- Target Price
- CVKD $32.00
- ADN N/A
- AVG Volume (30 Days)
- CVKD 31.8K
- ADN 27.2K
- Earning Date
- CVKD 08-06-2025
- ADN 08-19-2025
- Dividend Yield
- CVKD N/A
- ADN N/A
- EPS Growth
- CVKD N/A
- ADN N/A
- EPS
- CVKD N/A
- ADN N/A
- Revenue
- CVKD N/A
- ADN $670,000.00
- Revenue This Year
- CVKD N/A
- ADN $6,528.51
- Revenue Next Year
- CVKD N/A
- ADN N/A
- P/E Ratio
- CVKD N/A
- ADN N/A
- Revenue Growth
- CVKD N/A
- ADN N/A
- 52 Week Low
- CVKD $5.70
- ADN $1.71
- 52 Week High
- CVKD $22.90
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- CVKD 49.39
- ADN 34.26
- Support Level
- CVKD $11.00
- ADN $1.99
- Resistance Level
- CVKD $13.24
- ADN $2.18
- Average True Range (ATR)
- CVKD 1.10
- ADN 0.14
- MACD
- CVKD 0.17
- ADN -0.01
- Stochastic Oscillator
- CVKD 73.97
- ADN 1.75
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.